Retraction notice to "Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systemativ review and meta-analysis" [Curr. Res. Pharmacol. Drug Discov. 4C (2023) 100140].


Journal

Current research in pharmacology and drug discovery
ISSN: 2590-2571
Titre abrégé: Curr Res Pharmacol Drug Discov
Pays: Netherlands
ID NLM: 9918300982506676

Informations de publication

Date de publication:
2023
Historique:
pubmed: 28 7 2023
medline: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

[This retracts the article DOI: 10.1016/j.crphar.2022.100140.].

Identifiants

pubmed: 37502741
doi: 10.1016/j.crphar.2023.100154
pii: S2590-2571(23)00002-0
pmc: PMC10369383
doi:

Types de publication

Journal Article Retraction of Publication

Langues

eng

Pagination

100154

Commentaires et corrections

Type : RetractionOf

Informations de copyright

© 2023 Elsevier B.V. All rights reserved.

Auteurs

Anthéa Bertrand (A)

CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France.

Denis Gallot (D)

CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France.
Equipe, "Translationnal Approach to Epithelial Injury and Repair", Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000, Clermont-Ferrand, France.

Bruno Pereira (B)

CHU Clermont-Ferrand, Biostatistics Unit (DRCI) Department, Clermont-ferrand, France.

Amélie Delabaere (A)

CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France.
Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000, Clermont-Ferrand, France.

Classifications MeSH